Romanian stock indices close mixed in higher turnover
Bulgarian stock indices retreat amid higher turnover
Bulgaria to collect 2.1 bln euro for energy security fund in 2023
OECD downgrades Slovenia's 2023 GDP growth f'cast to 1.4%
Rompetrol Rafinare invests $6.5 mln in storage tanks overhaul
Nov 29, 2017 16:05 EEST
November 29 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] said on Wednesday its consolidated net profit rose to 32.7 million levs ($19.8 million/16.7 million euro) in the first nine months of 2017, from 31.6 million levs in the like period of 2016.
Sopharma’s operating revenue grew to 733.5 million levs in January-September, from 662.3 million levs in the prior-year period, the company said in a bourse filing.
The company’s consolidated operating expenses increased to 692.7 million levs in the review period, compared to 622.8 million levs the year before.
As at end-September, Sopharma had 1,896 employees. The company has subsidiaries in Moldova, Russia, Serbia, Belarus, Poland, Latvia, Lithuania, Ukraine and Kazakhstan.
(1 euro=1.95583 levs)
You have run out of free articles this month.
Sign up in for
and get ten (10) free articles per month or sign up for
and get unlimited access.
Browse our free newsletter options